Where did our name come from?

We’re called Q’Apel for the Qu’Appelle River, a waterway that winds through Saskatchewan, Canada. Why? Because this pristine river charts a winding path, full of twists, turns, and straightaways alike. That’s what we do, too. Our cutting-edge products—neurological catheters, specifically—are designed to navigate the twists and turns of the brain’s neurovasculature, empowering therapeutic thrombectomy and cerebral aneurysm devices to deliver life-changing outcomes.

Who We Are

Back To About

Chris Martin

Chris is President, Medical Devices & CFO of Research Corporation Technologies, Inc. (RCT). RCT is a technology investment company with over $800 million in assets. Along with his management responsibilities, Chris directs RCT’s medical device team and portfolio of investments. Chris is a Member of the RCT Board of Directors and serves on the board of a number of RCT’s portfolio companies. He received a BS in Biology from the University of Michigan, an MS in Biomedical Engineering from the University of Southern California, and an MBA from The Anderson School at UCLA.

Connect with Q’Apel.

By working side by side with neurological specialists and caregivers, we craft solutions that get straight to the heart of what’s needed. Reach out to learn more.

Get in touch